Estradiol side effects on TikTok: fact-checking the claims

What did @_lunacorn actually say?

@_lunacorn described feminizing hormone therapy as an emotional awakening, not a medical treatment. The video frames estradiol's side effects almost entirely through the lens of feeling more deeply: crying at commercials, mood swings that swing back fast, and a shift from "greyscale" to "full color" perception of the world. She also mentions asymmetric breast development and softer skin as physical changes. Her closing line, "it doesn't change your body, it teaches your heart how to see," is poetic but buries the clinical reality under metaphor.

To be fair, she's talking to a transgender audience about lived experience, not writing a prescribing guide. The emotional and psychological dimension of gender-affirming hormone therapy is genuinely underreported in mainstream health content. But 4,500 people watched this, and what they got was vibes. That's worth examining.

Does the science back this up?

Partly, yes. The emotional changes described are real and documented. But the video skips over the medically significant risks almost entirely, which makes it incomplete at best.

On the emotional side: estradiol does produce meaningful shifts in mood and affect. A 2018 study by Colizzi et al. in Journal of Endocrinological Investigation found significant improvements in psychological wellbeing and reductions in anxiety and depression in transgender women on hormone therapy. However, the same research noted that mood instability can worsen in some individuals, particularly in early months of treatment. The "I love everyone to I want to fight the clouds" swings she describes aren't just relatable content. They reflect real hormonal fluctuation, especially if estradiol levels aren't stable.

On breast development: asymmetry is genuinely common. A 2021 review by Seal in Best Practice and Research Clinical Endocrinology and Metabolism confirmed that breast development in transfeminine individuals mirrors pubescent development in cisgender girls, including asymmetry and tenderness. Her framing of this as "character development" is accurate in spirit.

What did they get wrong (or right)?

Here's where I have to be direct. @_lunacorn got the emotional texture of estradiol therapy largely right. The research does support increased emotional sensitivity, improved mood for many users, and a sense of psychological congruence. She deserves credit for normalizing the experience honestly rather than glamorizing it with no caveats.

What she got wrong by omission is significant. Estradiol carries real clinical risks that don't appear anywhere in this video. Venous thromboembolism risk is elevated, particularly with oral estradiol, compared to transdermal routes. A 2019 meta-analysis by Getahun et al. in Annals of Internal Medicine found a notably higher incidence of VTE in transfeminine individuals on hormone therapy compared to cisgender reference populations. There are also cardiovascular considerations, potential impacts on lipid panels, and for some individuals, prolactin elevation worth monitoring.

A 4,500-view video that tells people estradiol "teaches your heart how to see" without mentioning blood clot risk is doing incomplete work, regardless of how well-intentioned it is.

What should you actually know?

If you're considering estradiol as part of gender-affirming care or for any other indication, here's what the clinical picture actually looks like.

• Route of administration matters clinically. Transdermal estradiol carries lower VTE risk than oral formulations, according to Canonico et al., 2007, Circulation. This is a conversation to have with a prescriber, not something to skip because a TikTok made it sound simple.
• Mood changes are real but not universal. Some people experience significant emotional improvement. Others experience destabilization, particularly in the first three to six months when levels fluctuate. Regular monitoring matters.
• Breast asymmetry during development is common and usually resolves partially over time, but the timeline is unpredictable and varies by individual.
• Baseline labs and follow-up monitoring, including estradiol levels, liver function, and lipid panels, are standard of care for a reason. This is not optional.
• Psychological benefits are documented and clinically meaningful. The emotional changes @_lunacorn describes align with published outcomes data. But they sit alongside medical risks, not instead of them.

The emotional truth in this video is real. The clinical gaps are real too. You need both to make informed decisions about your health.